CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

K. Rejdak, M.J. Eikelenboom, A. Petzold, E.J. Thompson, Z. Stelmasiak, R.H.C. Lazeron, F. Barkhof, C.H. Polman, B.M.J. Uitdehaag, G. Giovannoni

Research output: Contribution to journalArticleAcademicpeer-review

92 Citations (Scopus)

Abstract

Objective: To investigate the relationship of CSF and the serum nitric oxide metabolites nitrite and nitrate (NOx) to disease activity and progression in patients with multiple sclerosis (MS). Methods: The study was divided into cross-sectional and follow-up. In the cross-sectional study, 20 patients with relapsing-remitting (RR), 21 with secondary progressive (SP), and 10 with primary progressive (PP) MS and 14 control subjects were included. Patients were assessed on clinical (Expanded Disability Status Scale [EDSS], Ambulation Index [AI], 9-Hole Peg Test [9-HPT]) and MRI measurements. In the follow-up study, 34 MS patients from the cross-sectional study agreed to be assessed again after an average of 3.0 ± 0.5 years. NOx was measured using a vanadium-based assay. Results: In the cross-sectional study, CSF NOx was raised in patients with RR-MS (p = 0.001) and PP-MS (p = 0.02) vs controls. Higher CSF NOx levels were found in patients with mild disability (AI ≤ 6.0; EDSS ≤ 4.0; Multiple Sclerosis Severity Score [MSSS] ≤ 4.8) vs patients with advanced disease (AI > 6.0 [p = 0.002]; EDSS > 4.0 [p = 0.02]; MSSS > 4.8 [p = 0.01]). In the subgroup of patients having Gd-enhancing MRI lesions (n = 11), correlation between the volume of enhancement and CSF NOx was found (r = 0.74, p = 0.01). In the follow-up study, patients with disability progression had higher baseline CSF NOx levels than those who were stable on EDSS (p = 0.02) or AI (p = 0.03). A positive correlation was found between baseline CSF NOx and the change in MR T2-weighted lesion load (r = 0.4, p = 0.03). Conclusions: CSF nitrite and nitrate levels were increased in mildly disabled patients with MS and found to correlate with the volume of Gd-enhanced lesions on MRI. Raised baseline CSF NOx was associated with clinical and MRI progression in MS patients over 3-year follow-up.

Original languageEnglish
Pages (from-to)1439-1445
Number of pages7
JournalNeurology
Volume63
Issue number8
Publication statusPublished - 26 Oct 2004
Externally publishedYes

Fingerprint

Multiple Sclerosis
Nitric Oxide
Walking
Chronic Progressive Multiple Sclerosis
Cross-Sectional Studies
Nitrites
Nitrates
Relapsing-Remitting Multiple Sclerosis
Vanadium
Disease Progression
Serum

Cite this

Rejdak, K., Eikelenboom, M. J., Petzold, A., Thompson, E. J., Stelmasiak, Z., Lazeron, R. H. C., ... Giovannoni, G. (2004). CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology, 63(8), 1439-1445.
Rejdak, K. ; Eikelenboom, M.J. ; Petzold, A. ; Thompson, E.J. ; Stelmasiak, Z. ; Lazeron, R.H.C. ; Barkhof, F. ; Polman, C.H. ; Uitdehaag, B.M.J. ; Giovannoni, G. / CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. In: Neurology. 2004 ; Vol. 63, No. 8. pp. 1439-1445.
@article{5197aa504a15438fb60842bcb092ddf2,
title = "CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis",
abstract = "Objective: To investigate the relationship of CSF and the serum nitric oxide metabolites nitrite and nitrate (NOx) to disease activity and progression in patients with multiple sclerosis (MS). Methods: The study was divided into cross-sectional and follow-up. In the cross-sectional study, 20 patients with relapsing-remitting (RR), 21 with secondary progressive (SP), and 10 with primary progressive (PP) MS and 14 control subjects were included. Patients were assessed on clinical (Expanded Disability Status Scale [EDSS], Ambulation Index [AI], 9-Hole Peg Test [9-HPT]) and MRI measurements. In the follow-up study, 34 MS patients from the cross-sectional study agreed to be assessed again after an average of 3.0 ± 0.5 years. NOx was measured using a vanadium-based assay. Results: In the cross-sectional study, CSF NOx was raised in patients with RR-MS (p = 0.001) and PP-MS (p = 0.02) vs controls. Higher CSF NOx levels were found in patients with mild disability (AI ≤ 6.0; EDSS ≤ 4.0; Multiple Sclerosis Severity Score [MSSS] ≤ 4.8) vs patients with advanced disease (AI > 6.0 [p = 0.002]; EDSS > 4.0 [p = 0.02]; MSSS > 4.8 [p = 0.01]). In the subgroup of patients having Gd-enhancing MRI lesions (n = 11), correlation between the volume of enhancement and CSF NOx was found (r = 0.74, p = 0.01). In the follow-up study, patients with disability progression had higher baseline CSF NOx levels than those who were stable on EDSS (p = 0.02) or AI (p = 0.03). A positive correlation was found between baseline CSF NOx and the change in MR T2-weighted lesion load (r = 0.4, p = 0.03). Conclusions: CSF nitrite and nitrate levels were increased in mildly disabled patients with MS and found to correlate with the volume of Gd-enhanced lesions on MRI. Raised baseline CSF NOx was associated with clinical and MRI progression in MS patients over 3-year follow-up.",
author = "K. Rejdak and M.J. Eikelenboom and A. Petzold and E.J. Thompson and Z. Stelmasiak and R.H.C. Lazeron and F. Barkhof and C.H. Polman and B.M.J. Uitdehaag and G. Giovannoni",
year = "2004",
month = "10",
day = "26",
language = "English",
volume = "63",
pages = "1439--1445",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "8",

}

Rejdak, K, Eikelenboom, MJ, Petzold, A, Thompson, EJ, Stelmasiak, Z, Lazeron, RHC, Barkhof, F, Polman, CH, Uitdehaag, BMJ & Giovannoni, G 2004, 'CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis', Neurology, vol. 63, no. 8, pp. 1439-1445.

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. / Rejdak, K.; Eikelenboom, M.J.; Petzold, A.; Thompson, E.J.; Stelmasiak, Z.; Lazeron, R.H.C.; Barkhof, F.; Polman, C.H.; Uitdehaag, B.M.J.; Giovannoni, G.

In: Neurology, Vol. 63, No. 8, 26.10.2004, p. 1439-1445.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

AU - Rejdak, K.

AU - Eikelenboom, M.J.

AU - Petzold, A.

AU - Thompson, E.J.

AU - Stelmasiak, Z.

AU - Lazeron, R.H.C.

AU - Barkhof, F.

AU - Polman, C.H.

AU - Uitdehaag, B.M.J.

AU - Giovannoni, G.

PY - 2004/10/26

Y1 - 2004/10/26

N2 - Objective: To investigate the relationship of CSF and the serum nitric oxide metabolites nitrite and nitrate (NOx) to disease activity and progression in patients with multiple sclerosis (MS). Methods: The study was divided into cross-sectional and follow-up. In the cross-sectional study, 20 patients with relapsing-remitting (RR), 21 with secondary progressive (SP), and 10 with primary progressive (PP) MS and 14 control subjects were included. Patients were assessed on clinical (Expanded Disability Status Scale [EDSS], Ambulation Index [AI], 9-Hole Peg Test [9-HPT]) and MRI measurements. In the follow-up study, 34 MS patients from the cross-sectional study agreed to be assessed again after an average of 3.0 ± 0.5 years. NOx was measured using a vanadium-based assay. Results: In the cross-sectional study, CSF NOx was raised in patients with RR-MS (p = 0.001) and PP-MS (p = 0.02) vs controls. Higher CSF NOx levels were found in patients with mild disability (AI ≤ 6.0; EDSS ≤ 4.0; Multiple Sclerosis Severity Score [MSSS] ≤ 4.8) vs patients with advanced disease (AI > 6.0 [p = 0.002]; EDSS > 4.0 [p = 0.02]; MSSS > 4.8 [p = 0.01]). In the subgroup of patients having Gd-enhancing MRI lesions (n = 11), correlation between the volume of enhancement and CSF NOx was found (r = 0.74, p = 0.01). In the follow-up study, patients with disability progression had higher baseline CSF NOx levels than those who were stable on EDSS (p = 0.02) or AI (p = 0.03). A positive correlation was found between baseline CSF NOx and the change in MR T2-weighted lesion load (r = 0.4, p = 0.03). Conclusions: CSF nitrite and nitrate levels were increased in mildly disabled patients with MS and found to correlate with the volume of Gd-enhanced lesions on MRI. Raised baseline CSF NOx was associated with clinical and MRI progression in MS patients over 3-year follow-up.

AB - Objective: To investigate the relationship of CSF and the serum nitric oxide metabolites nitrite and nitrate (NOx) to disease activity and progression in patients with multiple sclerosis (MS). Methods: The study was divided into cross-sectional and follow-up. In the cross-sectional study, 20 patients with relapsing-remitting (RR), 21 with secondary progressive (SP), and 10 with primary progressive (PP) MS and 14 control subjects were included. Patients were assessed on clinical (Expanded Disability Status Scale [EDSS], Ambulation Index [AI], 9-Hole Peg Test [9-HPT]) and MRI measurements. In the follow-up study, 34 MS patients from the cross-sectional study agreed to be assessed again after an average of 3.0 ± 0.5 years. NOx was measured using a vanadium-based assay. Results: In the cross-sectional study, CSF NOx was raised in patients with RR-MS (p = 0.001) and PP-MS (p = 0.02) vs controls. Higher CSF NOx levels were found in patients with mild disability (AI ≤ 6.0; EDSS ≤ 4.0; Multiple Sclerosis Severity Score [MSSS] ≤ 4.8) vs patients with advanced disease (AI > 6.0 [p = 0.002]; EDSS > 4.0 [p = 0.02]; MSSS > 4.8 [p = 0.01]). In the subgroup of patients having Gd-enhancing MRI lesions (n = 11), correlation between the volume of enhancement and CSF NOx was found (r = 0.74, p = 0.01). In the follow-up study, patients with disability progression had higher baseline CSF NOx levels than those who were stable on EDSS (p = 0.02) or AI (p = 0.03). A positive correlation was found between baseline CSF NOx and the change in MR T2-weighted lesion load (r = 0.4, p = 0.03). Conclusions: CSF nitrite and nitrate levels were increased in mildly disabled patients with MS and found to correlate with the volume of Gd-enhanced lesions on MRI. Raised baseline CSF NOx was associated with clinical and MRI progression in MS patients over 3-year follow-up.

UR - http://www.scopus.com/inward/record.url?scp=7044253039&partnerID=8YFLogxK

M3 - Article

C2 - 15505162

AN - SCOPUS:7044253039

VL - 63

SP - 1439

EP - 1445

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -

Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RHC et al. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology. 2004 Oct 26;63(8):1439-1445.